SI
SIGA.US SIGA Technologies Inc
- Market cap
- USD 204M
- P/E
- 284.0x
- P/B
- 1.21x
- ROE
- 5.0%
- Dividend yield
- 21.13%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SIGA.US undervalued?
Graham numberThe Graham number of SIGA Technologies Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SIGA Technologies Inc fundamental analysis
No fundamental analysis for SIGA Technologies Inc yet.
SIGA Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Full company profileSIGA Technologies Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SIGA Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 15.0M | 12.3M | 477M | 26.7M | 125M | 134M | 111M | 140M | 139M | 94.6M | 64.7M |
| Gross Profit | -4.72M | -4.41M | 369M | 11.7M | 99.2M | 117M | 100M | 122M | 107M | 64.9M | 36.6M |
| Operating Income | -31.0M | -18.8M | 355M | -2.32M | 84.5M | 89.1M | 42.7M | 83.6M | 70.0M | 23.7M | 2.75M |
| EBITDA | -25.4M | -23.4M | 355M | 6.12M | 77.1M | 89.8M | 44.7M | 88.3M | 76.6M | 31.0M | 7.50M |
| Net Income | -39.7M | -36.2M | 422M | -7.24M | 56.3M | 69.5M | 33.9M | 68.1M | 59.2M | 23.3M | 8.15M |
| EPS | -0.69 | -0.46 | 5.10 | -0.09 | 0.71 | 0.91 | 0.46 | 0.95 | 0.83 | 0.33 | 0.11 |
| Balance Sheet | |||||||||||
| Total Assets | 161M | 145M | 203M | 199M | 150M | 215M | 195M | 254M | 244M | 219M | 173M |
| Total Liabilities | 448M | 468M | 101M | 101M | 20.0M | 40.4M | 24.9M | 57.5M | 28.5M | 20.6M | 9.39M |
| Shareholders' Equity | -287M | -323M | 103M | 97.8M | 130M | 174M | 170M | 197M | 216M | 199M | 163M |
| Cash & Short-term Investments | 28.7M | 19.9M | 101M | 65.2M | 118M | 103M | 98.8M | 150M | 155M | 155M | 116M |
| Total Debt | 368B | 74.3M | 80.1M | 80.5M | 450K | 467K | 528K | 564K | 547K | 595K | 275K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -116M | -8.16M | 68.9M | -18.2M | 71.5M | 11.5M | 41.6M | 94.8M | 48.8M | 43.5M | 7.10M |
| Capital Expenditure | 23.9K | 100K | 102K | 29.1K | 15.5K | 50.6K | 0.00 | 21.7K | 42.5K | 355K | 13.33 |
| Free Cash Flow | -116M | -8.26M | 68.8M | -18.2M | 71.5M | 11.4M | 41.6M | 94.8M | 48.7M | 43.1M | 7.10M |
| Ratios | |||||||||||
| ROE | - | - | 409.9% | -7.4% | 43.4% | 39.8% | 19.9% | 34.6% | 27.4% | 11.7% | 5.0% |
| ROA | -24.7% | -25.0% | 207.3% | -3.6% | 37.6% | 32.3% | 17.4% | 26.8% | 24.2% | 10.6% | 4.7% |
| Net Profit Margin | -264.9% | -295.3% | 88.4% | -27.1% | 45.1% | 52.0% | 30.6% | 48.6% | 42.7% | 24.6% | 12.6% |
| Debt to Equity | - | - | 0.78x | 0.82x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SIGA Technologies Inc dividends
- Dividend yield
- 21.13%
- Forward dividend
- -
- Payout ratio
- 185.0%
- Ex-dividend date
- Apr 7, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 43.1M | 0.60 | 185.0% |
| 2024 | USD 42.7M | 0.59 | 72.1% |
| 2023 | USD 32.1M | 0.45 | 47.2% |
| 2022 | USD 32.9M | 0.45 | 97.2% |
| 2021 | USD 32.9M | 0.43 | 47.4% |
| 2020 | USD 32.9M | 0.41 | 58.5% |
| 2019 | USD 32.9M | 0.40 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns SIGA Technologies Inc
- Insiders 42.73%
- Institutions 47.87%
- Public & others 9.40%
- Shares outstanding 71.9M
- Free float 41.1M
Top funds holding SIGA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Avantis US Small Cap Value ETF | 1.29M | 1.80% | 0.00% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.21M | 1.68% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.11M | 1.54% | 0.00% | Oct 2026 |
| Fidelity Small Cap Index | 476K | 0.66% | +2.66% | Aug 2026 |
| iShares Russell 2000 Value ETF | 439K | 0.61% | 0.00% | Oct 2026 |
| DFA U.S. Targeted Value I | 387K | 0.54% | -15.34% | Sep 2026 |
| DFA U.S. Small Cap Value I | 356K | 0.50% | +24.43% | Sep 2026 |
| DFA U.S. Small Cap I | 315K | 0.44% | 0.00% | Sep 2026 |
| DFA US Micro Cap I | 256K | 0.36% | 0.00% | Sep 2026 |
| Victory Small Cap Stock | 245K | 0.34% | 0.00% | Sep 2026 |
| Vanguard Russell 2000 ETF | 245K | 0.34% | +0.29% | Sep 2026 |
| Hotchkis & Wiley Sm Cp Divers Val I | 240K | 0.33% | 0.00% | Sep 2026 |
| BlackRock Advantage Small Cap Core Instl | 229K | 0.32% | +1,389.21% | Sep 2026 |
| Fidelity Extended Market Index | 226K | 0.32% | -0.38% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 222K | 0.31% | +0.23% | Oct 2026 |
| Dimensional US Core Equity 2 ETF | 184K | 0.26% | 0.00% | Oct 2026 |
| Multi-Manager Small Cap Eq Strat Inst | 183K | 0.25% | 0.00% | Sep 2026 |
| Cambria Micro and Smcp Shld Yld ETF | 153K | 0.21% | 0.00% | Oct 2026 |
| U.S. Equity Small Cap Corporate Cl OF | 143K | 0.20% | 0.00% | Jun 2026 |
| Bridge Builder Small Cap Fund | 137K | 0.19% | +4,435.43% | Oct 2026 |
Top institutions holding SIGA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 4.19M | 5.83% | +19.81% | Jun 2026 |
| AltraVue Capital, LLC | 2.33M | 3.24% | -4.31% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 2.01M | 2.80% | -26.03% | Sep 2026 |
| Vanguard Capital Management, LLC | 1.71M | 2.38% | -0.10% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 1.47M | 2.05% | -3.35% | Jun 2026 |
| American Century Companies Inc | 1.43M | 1.99% | -5.04% | Sep 2026 |
| Geode Capital Management, LLC | 1.42M | 1.97% | +7.72% | Jun 2026 |
| First Wilshire Securities Mgmt Inc (CA) | 1.34M | 1.86% | +50.46% | Jun 2026 |
| AQR Capital Management LLC | 1.25M | 1.73% | +2.16% | Jun 2026 |
| State Street Corp | 1.13M | 1.58% | +12.06% | Jun 2026 |
| Hotchkis & Wiley Capital Management LLC | 914K | 1.27% | +10.52% | Jun 2026 |
| Qube Research & Technologies | 741K | 1.03% | +78.49% | Jun 2026 |
| Renaissance Technologies Corp | 637K | 0.89% | +49.66% | Sep 2026 |
| New York State Common Retirement Fund | 591K | 0.82% | 0.00% | Jun 2026 |
| Millennium Management LLC | 580K | 0.81% | +24.29% | Jun 2026 |
| Jacobs Levy Equity Management, Inc. | 567K | 0.79% | +94.23% | Jun 2026 |
| Uniplan Investment Counsel, Inc. | 560K | 0.78% | +50.87% | Jun 2026 |
| Citadel Advisors Llc | 551K | 0.77% | -21.82% | Jun 2026 |
| Royce & Associates, LP | 551K | 0.77% | -17.47% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 550K | 0.77% | -6.35% | Jun 2026 |
SIGA Technologies Inc company profile
- Company name
- SIGA Technologies Inc
- Ticker
- SIGA.US
- Exchange
- USA Stocks
- Listed since
- Sep 9, 1997
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 49
- Fiscal year end
- December
- Address
- 31 East 62nd Street, New York, NY, United States, 10065
- Phone
- 212 672 9100
- Website
- siga.com
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
SIGA Technologies Inc management
6- Dr. Diem Nguyen M.B.A., Ph.D.CEO & Director · born 1972
- Mr. Daniel J. Luckshire CPA, M.B.A.Executive VP, CFO & Secretary · born 1971
- Dr. Dennis E. Hruby Ph.D.Executive VP & Chief Scientific Officer · born 1952
- Mr. Lawrence R. Miller Esq., J.D.General Counsel & Corporate Secretary · born 1968
- Mr. Herb VloedmanSenior VP & Chief Information Officer
- Suzanne HarnettSenior Vice President of Corporate Affairs & Investor Relations